Moderna Inc MRNA:NASDAQ
RT Quote | Last NASDAQ LS, VOL From CTA | USD
After Hours: Last | 09/30/22 EDT118.28
+0.03 (+0.03%)
+0.03 (+0.03%)Volume
124,190
Close
118.25+0.18 (+0.15%)
+0.18 (+0.15%)Volume
3,705,401
52 week range
115.03 - 390.60
- Open118.44
- Day High122.58
- Day Low118.08
- Prev Close118.07
- 52 Week High390.60
- 52 Week High Date09/30/21
- 52 Week Low115.03
- 52 Week Low Date09/29/22
Key Stats
- Market Cap46.259B
- Shares Out391.20M
- 10 Day Average Volume5.55M
- Dividend-
- Dividend Yield-
- Beta1.71
- YTD % Change-53.44
KEY STATS
- Open118.44
- Day High122.58
- Day Low118.08
- Prev Close118.07
- 52 Week High390.60
- 52 Week High Date09/30/21
- 52 Week Low115.03
- 52 Week Low Date09/29/22
- Market Cap46.259B
- Shares Out391.20M
- 10 Day Average Volume5.55M
- Dividend-
- Dividend Yield-
- Beta1.71
- YTD % Change-53.44
RATIOS/PROFITABILITY
- EPS (TTM)32.80
- P/E (TTM)3.60
- Fwd P/E (NTM)7.65
- EBITDA (TTM)15.945B
- ROE (TTM)113.86%
- Revenue (TTM)22.995B
- Gross Margin (TTM)82.29%
- Net Margin (TTM)61.12%
- Debt To Equity (MRQ)4.24%
EVENTS
- Earnings Date11/02/2022(est)
- Ex Div Date-
- Div Amount-
- Split Date-
- Split Factor-
Latest On Moderna Inc
Content From Our Affiliates
Related Video
Profile
MOREModerna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan Ph.D.
Non-Executive Independent Chairman of the Board, Co-Founder
Stephane Bancel
Chief Executive Officer, Director
Stephen Hoge M.D.
President
James Mock
Chief Financial Officer
Juan Andres
Chief Technical Operations and Quality Officer
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States
Top Peers
| SYMBOL | LAST | CHG | %CHG |
|---|---|---|---|
BNTX BioNTech SE | 134.88 | +1.28 | +0.96% |
REGN Regeneron Pharmaceuticals Inc | 688.87 | -2.95 | -0.43% |
BIIB Biogen Inc | 267.00 | +2.72 | +1.03% |
ILMN Illumina Inc | 190.79 | -3.02 | -1.56% |
ALNY Alnylam Pharmaceuticals Inc | 200.16 | -9.23 | -4.41% |